BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15982657)

  • 1. Rho and vascular disease.
    Rolfe BE; Worth NF; World CJ; Campbell JH; Campbell GR
    Atherosclerosis; 2005 Nov; 183(1):1-16. PubMed ID: 15982657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.
    Sarrabayrouse G; Pich C; Teiti I; Tilkin-Mariame AF
    Int J Cancer; 2017 Feb; 140(4):747-755. PubMed ID: 27616679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Between Rho(k) and a hard place: the relation between vessel wall stiffness, endothelial contractility, and cardiovascular disease.
    Huveneers S; Daemen MJ; Hordijk PL
    Circ Res; 2015 Feb; 116(5):895-908. PubMed ID: 25722443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling.
    Wojciak-Stothard B
    Postgrad Med J; 2008 Jul; 84(993):348-53. PubMed ID: 18716013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RHO SIGNALING in vascular diseases.
    Seasholtz TM; Brown JH
    Mol Interv; 2004 Dec; 4(6):348-57. PubMed ID: 15616164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells.
    Cernuda-Morollón E; Ridley AJ
    Circ Res; 2006 Mar; 98(6):757-67. PubMed ID: 16574916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin.
    Jacobson JR; Dudek SM; Birukov KG; Ye SQ; Grigoryev DN; Girgis RE; Garcia JG
    Am J Respir Cell Mol Biol; 2004 May; 30(5):662-70. PubMed ID: 14630613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system.
    van Nieuw Amerongen GP; van Hinsbergh VW
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):300-11. PubMed ID: 11231907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type VIII collagen signals via β1 integrin and RhoA to regulate MMP-2 expression and smooth muscle cell migration.
    Adiguzel E; Hou G; Sabatini PJ; Bendeck MP
    Matrix Biol; 2013 Aug; 32(6):332-41. PubMed ID: 23523587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
    Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
    Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rho and Rho-kinase].
    Sato J; Iiri T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
    [No Abstract]   [Full Text] [Related]  

  • 17. Geranylgeranylation but not GTP-loading of Rho GTPases determines T cell function.
    Waiczies S; Bendix I; Zipp F
    Sci Signal; 2008 Mar; 1(12):pt3. PubMed ID: 18364514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho GTPases as therapeutic targets for the treatment of inflammatory diseases.
    Zhao D; Pothoulakis C
    Expert Opin Ther Targets; 2003 Oct; 7(5):583-92. PubMed ID: 14498821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro model to study the role of endothelial rho GTPases during leukocyte transendothelial migration.
    Millán J; Williams L; Ridley AJ
    Methods Enzymol; 2006; 406():643-55. PubMed ID: 16472694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
    Sawada N; Itoh H; Nakao K
    Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.